| Amy K Mehta, MD | |
|
3838 San Dimas St, Building A Suite 250, Bakersfield, CA 93301-2284 | |
| (661) 323-5300 | |
| Not Available |
| Full Name | Amy K Mehta |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 17 Years |
| Location | 3838 San Dimas St, Bakersfield, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558553347 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | A106378 (California) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | A106378 (California) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.
Beach sand contains all kinds of microorganisms, including those that can harm human health. Yet current guidelines are focused exclusively on monitoring the levels of microbes in the water.
AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, presented data at the European Congress of Clinical Microbiology and Infectious Diseases summarizing both the in vitro and in vivo activity of its proprietary, investigational phage mix AB-PA01.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 16th Annual Connective Tissue Oncology Society (CTOS) Meeting taking place in Paris, France from November 11 to 13, 2010.
Medtronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, the next generation of the industry's only integrated diabetes management system (insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software).
› Verified 6 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979834 PECOS PAC ID: 6002729175 Enrollment ID: O20040126000823 |
News Archive
A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.
Beach sand contains all kinds of microorganisms, including those that can harm human health. Yet current guidelines are focused exclusively on monitoring the levels of microbes in the water.
AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, presented data at the European Congress of Clinical Microbiology and Infectious Diseases summarizing both the in vitro and in vivo activity of its proprietary, investigational phage mix AB-PA01.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 16th Annual Connective Tissue Oncology Society (CTOS) Meeting taking place in Paris, France from November 11 to 13, 2010.
Medtronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, the next generation of the industry's only integrated diabetes management system (insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software).
› Verified 6 days ago
| Entity Name | Premier Hospitalists Of Bakersfield Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770525016 PECOS PAC ID: 6800895103 Enrollment ID: O20061214000434 |
News Archive
A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.
Beach sand contains all kinds of microorganisms, including those that can harm human health. Yet current guidelines are focused exclusively on monitoring the levels of microbes in the water.
AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, presented data at the European Congress of Clinical Microbiology and Infectious Diseases summarizing both the in vitro and in vivo activity of its proprietary, investigational phage mix AB-PA01.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 16th Annual Connective Tissue Oncology Society (CTOS) Meeting taking place in Paris, France from November 11 to 13, 2010.
Medtronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, the next generation of the industry's only integrated diabetes management system (insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy K Mehta, MD 3838 San Dimas St, Building A Suite 250, Bakersfield, CA 93301-2284 Ph: (661) 323-5300 | Amy K Mehta, MD 3838 San Dimas St, Building A Suite 250, Bakersfield, CA 93301-2284 Ph: (661) 323-5300 |
News Archive
A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell.
Beach sand contains all kinds of microorganisms, including those that can harm human health. Yet current guidelines are focused exclusively on monitoring the levels of microbes in the water.
AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, presented data at the European Congress of Clinical Microbiology and Infectious Diseases summarizing both the in vitro and in vivo activity of its proprietary, investigational phage mix AB-PA01.
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 16th Annual Connective Tissue Oncology Society (CTOS) Meeting taking place in Paris, France from November 11 to 13, 2010.
Medtronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, the next generation of the industry's only integrated diabetes management system (insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software).
› Verified 6 days ago
Marsha Cheng, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 Wible Rd Ste 14, Bakersfield, CA 93304 Phone: 661-835-1240 Fax: 661-835-4667 | |
Sarah Dowda, NP Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 8327 Brimhall Rd Ste 704, Bakersfield, CA 93312 Phone: 661-829-7677 Fax: 661-679-6920 | |
Peter Alagona Jr., M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600 | |
Paramvir Singh Rahal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9802 Stockdale Hwy, Ste 102, Bakersfield, CA 93311 Phone: 661-323-1200 Fax: 661-616-5339 | |
Harieet Singh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2415 Niles St, Bakersfield, CA 93306 Phone: 661-631-1591 Fax: 661-631-1594 | |
Bruce G Dains, PAC Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2701 Chester Ave, Highgrove Medical Center, Bakersfield, CA 93301 Phone: 661-326-1600 Fax: 661-323-2307 | |
Dr. Oscar W. Rico, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 9001 Stockdale Hwy, 28 Hc, Bakersfield, CA 93311 Phone: 661-654-2395 |